Morning Headlines 6/19/17
Fostering Medical Innovation: A Plan for Digital Health Devices
FDA Commissioner Scott Gottlieb, MD describes his plans for regulating digital health innovation, saying that the FDA “should carry out its mission to protect and promote the public health through policies that are clear enough for developers to apply them on their own, without having to seek out, on a case-by-case basis.”
On AHCA, CMS Actuary Finds Smaller Coverage Losses, Smaller Spending Reductions Than CBO
The Office of the Chief Actuary of CMS forecasts a 13 million reduction in insured patients by 2026 if AHCA is passed, 10 million less than the CBO’s prediction.
Kaiser Permanente Medical Group CEO Robert Pearl, MD outlines the lessons he learned while working on the health system’s $4 billion Epic implementation.
Baby Genome Sequencing for Sale in China
Boston-based DNA sequencing company Veritas Genetics is offering full genome sequencing to parents in China. The sequencing report addresses 950 inherited diseases, as well as 200 genes connected to drug reactions, and 100 physical traits the child is likely to have.
White House task force echoes pharma proposals
STAT reports that behind-the-scenes discussions being held by the Trump administration on how to reign in drug prices are being influenced by lobbyists for the pharmaceutical industry.
Sounds reasonable, until you look at the Silicon Valley experience. Silicon Valley grew like a weed precisely because employees could…